Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-05

FDA Approved: BOSENTAN — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' original application for a generic Bosentan, enabling a generic version of the endothelin receptor antagonist to treat p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bosentan (Bosentan)

Snippet

ORIG AP for BOSENTAN (BOSENTAN)